Matthias Aizenberg

For decades, cancers driven by RAS gene mutations have posed one of the most formidable challenges in oncology, with these mutations being among the most common drivers of human cancers yet notoriously difficult to target with therapeutic agents. In a significant development that offers new hope

For millions of people battling cancer, the promise of chemotherapy is a lifeline tethered to an agonizing paradox: the very treatment designed to save them can simultaneously inflict debilitating, long-term nerve damage. This cruel reality forces an impossible choice between enduring a cure and

Today we’re speaking with Ivan Kairatov, a biopharma expert with a deep understanding of how technology and innovation are reshaping the industry. We'll be exploring the fascinating and complex gap between the theoretical promise of AI in medicine and its real-world performance. The conversation

Beyond the malignant cells of a brain tumor lies an equally destructive force, a relentless physical pressure that silently and systematically dismantles the delicate architecture of the mind long before the cancer itself infiltrates surrounding tissue. While medical science has long focused on

As a biopharma expert deeply involved in technological innovation, Ivan Kairatov has been at the forefront of applying advanced science to solve critical industry challenges. Today, he joins us to discuss a groundbreaking development in food safety: an artificial intelligence system that

The landscape of modern medicine is undergoing a profound transformation, shifting from a reactive model of treating symptoms to a proactive strategy focused on early detection and prevention. This evolution is fueling an unprecedented surge in advanced diagnostic technologies, with whole body

For men who have undergone surgery to remove their prostate, a subsequent rise in a key blood marker often signals the cancer's return, plunging them into a period of clinical uncertainty where the next steps have historically been guided more by protocol than precision. This research summary

Today we're speaking with Ivan Kairatov, a biopharma expert with deep insights into the intersection of technology and clinical research. We'll be exploring a groundbreaking study on an AI-powered stethoscope that could fundamentally change how we screen for heart disease. Our discussion will cover

The immense success of messenger RNA vaccines painted a tantalizing picture of a medical revolution, yet the very technology that made them possible has also been a barrier to their wider therapeutic use. While transformative in preventing infectious diseases, the first generation of mRNA delivery

A baffling contradiction has long stood at the heart of understanding how one of the most aggressive forms of breast cancer spreads throughout the body, but new research has finally unraveled this mystery, revealing a unique survival strategy that cancer cells use to become metastatic. For years,